Craft
Smith & Nephew

Smith & Nephew

Training Provided, no. of people

90 K

FY, 2016

Revenue

$5.2 B

FY, 2021

Market Capitalization

£10 B

2023-01-20

Smith & Nephew Summary

Company summary

Overview
Smith & Nephew is a medical technology company. It operates in three main segments: Orthopaedic Reconstruction and Trauma, Endoscopy and Advanced Wound Management. The company offers sports medicine joint repair products for surgeons, arthroscopic enabling technologies for healthcare providers, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, electromechanical and mechanical tissue resection devices, etc. 
Type
Public
Status
Active
Founded
1856
HQ
Watford, GB | view all locations
Website
https://www.smith-nephew.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key people

  • Brad Cannon, President Orthopaedics, Sports Medicine and ENT and Americas

    • Anne-Françoise Nesmes, Chief Financial Officer and Director

    • Elga Lohler, Chief Human Resources Officer

      • Helen Barraclough, Group General Counsel

      Operating MetricsView all

      Training Provided, no. of people

      90K

      FY, 2016

      LocationsView all

      9 locations detected

      • Watford, England HQ

        United Kingdom

        Building 5, Croxley Park Hatters Lane

      • Andover, MA

        United States

        150 Minuteman Rd

      • Fort Worth, TX

        United States

        5600 Clearfork Main St Suite 600

      • Memphis, TN

        United States

        1450 Brooks Road

      • Memphis, TN

        United States

        7135 Goodlett Farms Pkwy, Cordova

      • São Paulo, SP

        Brazil

        Floor 23 Tower C, Rochaverá Corporate Towers

      and 3 others

      Smith & Nephew Financials

      Summary financials

      Revenue (H1, 2023)
      $2.6B
      Gross profit (H1, 2023)
      $2.1B
      Net income (H1, 2023)
      $177.0M
      Cash (H1, 2023)
      $516.0M
      EBIT (H1, 2023)
      $241.0M
      Enterprise value
      $12.4B

      Footer menu